Literature DB >> 29878363

Resection of retroperitoneal sarcoma en-bloc with inferior vena cava: 20 year outcomes of a single institution.

Alex B Blair1, Bradley N Reames1, Jasvinder Singh1, Faiz Gani1, Heidi N Overton1, Robert J Beaulieu1, Ying W Lum2, James H Black2, Fabian M Johnston1, Nita Ahuja3.   

Abstract

BACKGROUND: Margin negative resection offers the best chance of long-term survival in retroperitoneal sarcoma (RPS). En-bloc resection of adjacent structures, including the inferior vena cava (IVC), is often required to achieve negative margins. We review our 20-year experience of en-bloc IVC and RPS resection.
METHODS: Retrospective review of patients with RPS resection involving the IVC were matched 1:3 by age and histology to RPS without IVC resection. Prognostic factors for overall survival (OS) and disease free survival (DFS) were assessed.
RESULTS: Thirty-two patients underwent RPS resection en-bloc with IVC. They were matched with 96 cases of RPS without IVC resection. Median OS of 59 months and DFS 18 months in IVC resection group was comparable to RPS resection without vascular involvement: median OS 65 months, DFS 18 months (P = 0.519, P = 0.604). On multivariate analyses, R2 margin (OS: HR = 6.52 [95%CI: 1.18-36.09], P = 0.032) was associated with inferior OS. R2 margin and increased number of organs resected (DFS: HR = 5.07, [1.15-22.27], P = 0.031, HR = 1.28 [1.01-1.62], P = 0.014) were associated with inferior DFS. Reconstructions included graft (n = 19, 59%), patch (n = 4, 13%), primary repair (n = 6, 19%), and ligation (n = 4, 13%).
CONCLUSIONS: RPS resection en-bloc with IVC can achieve equivalent rates of DFS and OS to patients without vascular involvement.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  inferior vena cava; sarcoma; survival; vascular resection

Mesh:

Year:  2018        PMID: 29878363      PMCID: PMC6220674          DOI: 10.1002/jso.25096

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  42 in total

1.  Resection of the abdominal inferior vena cava for complicated renal cell carcinoma with tumour thrombus.

Authors:  Gaetano Ciancio; Mark Soloway
Journal:  BJU Int       Date:  2005-10       Impact factor: 5.588

2.  Leiomyosarcoma of the inferior vena cava: prognosis and comparison with leiomyosarcoma of other anatomic sites.

Authors:  O J Hines; S Nelson; W J Quinones-Baldrich; F R Eilber
Journal:  Cancer       Date:  1999-03-01       Impact factor: 6.860

Review 3.  Clinical results of surgery for retroperitoneal sarcoma with major blood vessel involvement.

Authors:  Matthias H M Schwarzbach; Yura Hormann; Ulf Hinz; Christine Leowardi; Dittmar Böckler; Gunhild Mechtersheimer; Helmut Friess; Markus W Büchler; Jens-R Allenberg
Journal:  J Vasc Surg       Date:  2006-07       Impact factor: 4.268

4.  Variability in Patterns of Recurrence After Resection of Primary Retroperitoneal Sarcoma (RPS): A Report on 1007 Patients From the Multi-institutional Collaborative RPS Working Group.

Authors:  Alessandro Gronchi; Dirk C Strauss; Rosalba Miceli; Sylvie Bonvalot; Carol J Swallow; Peter Hohenberger; Frits Van Coevorden; Piotr Rutkowski; Dario Callegaro; Andrew J Hayes; Charles Honoré; Mark Fairweather; Amanda Cannell; Jens Jakob; Rick L Haas; Milena Szacht; Marco Fiore; Paolo G Casali; Raphael E Pollock; Chandrajit P Raut
Journal:  Ann Surg       Date:  2016-05       Impact factor: 12.969

5.  Inferior vena cava leiomyosarcoma: is reconstruction necessary after resection?

Authors:  Rouzbeh Daylami; Amir Amiri; Brian Goldsmith; Christoph Troppmann; Philip D Schneider; Vijay P Khatri
Journal:  J Am Coll Surg       Date:  2010-02       Impact factor: 6.113

6.  Pancreaticoduodenectomy with vascular resection: margin status and survival duration.

Authors:  Jennifer F Tseng; Chandrajit P Raut; Jeffrey E Lee; Peter W T Pisters; Jean-Nicolas Vauthey; Eddie K Abdalla; Henry F Gomez; Charlotte C Sun; Christopher H Crane; Robert A Wolff; Douglas B Evans
Journal:  J Gastrointest Surg       Date:  2004-12       Impact factor: 3.452

7.  Primary retroperitoneal sarcomas: a multivariate analysis of surgical factors associated with local control.

Authors:  Sylvie Bonvalot; Michel Rivoire; Marine Castaing; Eberhard Stoeckle; Axel Le Cesne; Jean Yves Blay; Agnès Laplanche
Journal:  J Clin Oncol       Date:  2008-12-01       Impact factor: 44.544

8.  Histologic subtype and margin of resection predict pattern of recurrence and survival for retroperitoneal liposarcoma.

Authors:  Samuel Singer; Cristina R Antonescu; Elyn Riedel; Murray F Brennan
Journal:  Ann Surg       Date:  2003-09       Impact factor: 12.969

9.  Sarcoma Resection With and Without Vascular Reconstruction: A Matched Case-control Study.

Authors:  George A Poultsides; Thuy B Tran; Eduardo Zambrano; Lucas Janson; David G Mohler; Matthew W Mell; Raffi S Avedian; Brendan C Visser; Jason T Lee; Kristen Ganjoo; E John Harris; Jeffrey A Norton
Journal:  Ann Surg       Date:  2015-10       Impact factor: 12.969

10.  The risk of venous thromboembolism in renal cell carcinoma patients with residual tumor thrombus.

Authors:  R Ihaddadene; D W Yokom; G Le Gal; P Moretto; C M Canil; A Delluc; N Reaume; M Carrier
Journal:  J Thromb Haemost       Date:  2014-06       Impact factor: 5.824

View more
  3 in total

1.  Contralateral internal iliac artery transposition for retroperitoneal sarcoma involving common iliac artery.

Authors:  Cheng-Peng Li; Bo-Nan Liu; Jian-Hui Wu; Chun-Yi Hao
Journal:  Updates Surg       Date:  2020-06-29

2.  Approaches to reconstruction of inferior vena cava by ex vivo liver resection and autotransplantation in 114 patients with hepatic alveolar echinococcosis.

Authors:  Yusufukadier Maimaitinijiati; Tuerganaili AJi; Tie-Min Jiang; Bo Ran; Ying-Mei Shao; Rui-Qing Zhang; Qiang Guo; Mao-Lin Wang; Hao Wen
Journal:  World J Gastroenterol       Date:  2022-08-21       Impact factor: 5.374

3.  Novel use of the falciform ligament for reconstruction of the inferior vena cava and its tributary.

Authors:  Janet W C Kung; Charing C N Chong; Kit-Fai Lee; John Wong; Paul B S Lai; Kelvin K C Ng
Journal:  J Vasc Surg Cases Innov Tech       Date:  2021-06-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.